期刊
CURRENT PHARMACEUTICAL DESIGN
卷 26, 期 16, 页码 1778-1789出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612826666200212114843
关键词
Lactose; antioxidant; excipient; food; interaction; intolerance
资金
- UVa-GIR (Recognized Research Group from the Valladolid University)
- Complutense University UCM-CAM (Comunidad Autonoma de Madrid-Universidad Complutense de Madrid) research group [971702]
Lactose is a reducing sugar consisting of galactose and glucose, linked by a beta (1 -> 4) glycosidic bond, considered as an antioxidant due to its a-hydroxycarbonyl group. Lactose is widely ingested through the milk and other unfermented dairy products and is considered to be one of the primary foods. On the other hand, lactose is also considered as one of the most widely used excipients for the development of pharmaceutical formulations. In this sense, lactose has been related to numerous drug-excipient or drug-food pharmacokinetic interactions. Intolerance, maldigestion and malabsorption of carbohydrates are common disorders in clinical practice, with lactose-intolerance being the most frequently diagnosed, afflicting 10% of the world's population. Four clinical subtypes of lactose intolerance may be distinguished, namely lactase deficiency in premature infants, congenital lactase deficiency, adult-type hypolactasia and secondary lactase intolerance. An overview of the main uses of lactose in human nutrition and in the pharmaceutical industry and the problems derived from this circumstance are described in this review.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据